Objectives To explore the prognostic value of subclinical cardiovascular (CV) imaging
measures and serum cardiac biomarkers in systemic sclerosis (SSc) for the development of …

Aims Cardiovascular involvement in systemic sclerosis (SSc) is heterogeneous and ill-
defined. This study aimed to:(i) discover cardiac phenotypes in SSc by cardiovascular …

Objectives SSc primary heart involvement (SSc-pHI) is a significant cause of mortality. We
aimed to characterize and identify predictors of subclinical SSc-pHI using cardiovascular …

Objectives Cardiovascular involvement is recognized as a poor prognostic factor in systemic
sclerosis (SSc). The aim of this study was to evaluate the usefulness of nailfold video …

Aims Myocardial involvement is common in patients with systemic sclerosis (SSc) and
causes myocardial fibrosis and subtle ventricular dysfunction. However, the temporal onset …

Introduction In previous studies we showed that prevalence of myocardial fibrosis as
assessed by late enhancement on cardiac MRI in SSc patients is 45% and is associated to …

Background To determine morphological and functional cardiovascular magnetic resonance
(CMR) patterns in histopathologically confirmed myocardial involvement in patients with …

Aims Cardiac disease in systemic sclerosis (SSc) may be primary or secondary to other
disease manifestations of SSc. The prevalence of the primary cardiomyopathy of SSc is …

Background: Acute cardiac events are a significant contributor to mortality in systemic
sclerosis (SSc). However, echocardiographic evaluation may be deceptively normal during …

Background Cardiac involvement in systemic sclerosis (SSc) is associated with a variable
phenotype including heart failure, arrhythmias and pulmonary hypertension. The aim of the …